SYRS – syros pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
BlossomHill Therapeutics Appoints Geoff Oxnard, M.D., as Chief Medical Officer and Executive Vice President [Yahoo! Finance]
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Form 144 Syros Pharmaceuticals, Filed by: AKKARAJU SRINIVAS
Form 144 Syros Pharmaceuticals, Filed by: Flagship Pioneering Fund VII, L.P.
Form 144 Syros Pharmaceuticals, Filed by: Flagship VentureLabs IV, LLC
Form 144 Syros Pharmaceuticals, Filed by: Flagship Pioneering Fund VII, L.P.
Form 144 Syros Pharmaceuticals, Filed by: Flagship Ventures Fund IV-Rx, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.